Catalyst Pharmaceuticals Inc (CPRX) financials · rev $589.0M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Catalyst Pharmaceuticals Inc (CPRX) rev $589.0M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $589.0M | $491.7M |
| Cost of Revenue | $87.3M | $68.8M |
| Gross Profit | $501.7M | $422.9M |
| Operating Income | $257.8M | $195.1M |
| Net Income | $214.3M | $163.9M |
| EPS (Diluted) | $1.68 | $1.31 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $1.10B | $851.4M |
| Current Assets | $894.0M | $623.6M |
| Cash & Equivalents | $709.2M | $517.6M |
| Inventory | $37.2M | $19.5M |
| PP&E | $1.04M | $1.35M |
| Total Liabilities | $149.7M | $123.8M |
| Current Liabilities | $147.2M | $120.7M |
| Shareholders' Equity | $954.3M | $727.6M |
| Retained Earnings | $474.2M | $285.2M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | $208.7M | $239.8M |
| CapEx | $58.0K | $556.0K |
| Investing Cash Flow | -$58.0K | -$556.0K |
| Financing Cash Flow | -$17.0M | $140.7M |
| Free Cash Flow | $208.6M | $239.3M |
FAQ
What is CPRX P/E and revenue?
Catalyst Pharmaceuticals Inc (CPRX) rev $589.0M.
What is CPRX revenue?
Catalyst Pharmaceuticals Inc last cached revenue is $589.0M (FY2025).
Is CPRX profitable?
Catalyst Pharmaceuticals Inc last cached net income is $214.3M (FY2025).
What are CPRX total assets?
Catalyst Pharmaceuticals Inc last cached total assets are $1.10B (FY2025).
What is CPRX free cash flow?
Catalyst Pharmaceuticals Inc last cached free cash flow is $208.6M (FY2025).
Not investment advice. Cached statements, not a live tape.